Long-term effectiveness and cost-effectiveness of an 18-week supervised exercise program in patients treated with autologous stem cell transplantation: results from the EXIST study.
Adult
Cancer Survivors
/ statistics & numerical data
Cardiorespiratory Fitness
/ physiology
Cost-Benefit Analysis
Exercise Therapy
/ economics
Fatigue
/ epidemiology
Female
Follow-Up Studies
Hand Strength
/ physiology
Hematologic Neoplasms
/ economics
Hematopoietic Stem Cell Transplantation
/ statistics & numerical data
Humans
Male
Middle Aged
Netherlands
/ epidemiology
Physical Fitness
/ physiology
Quality of Life
Quality-Adjusted Life Years
Surveys and Questionnaires
Transplantation, Autologous
/ statistics & numerical data
Treatment Outcome
Cost-effectiveness
Exercise intervention
Long-term effectiveness
Lymphoma
Multiple myeloma
Journal
Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
15
02
2019
accepted:
12
06
2019
pubmed:
10
7
2019
medline:
5
6
2020
entrez:
10
7
2019
Statut:
ppublish
Résumé
To evaluate the long-term effectiveness and cost-effectiveness of a supervised 18-week high-intensity exercise program compared with usual care in patients treated with autologous stem cell transplantation. One hundred nine patients were randomly assigned to the exercise intervention (n = 54) or the usual care control group (n = 55). Data on cardiorespiratory fitness (VO At T2, no statistically significant differences were found between the intervention and control group for VO We found no evidence for the exercise intervention being effective on physical fitness and fatigue, nor cost-effective from a societal perspective. The study was prospectively registered on 27 May 2010 at the Netherlands Trial Register ( NTR2341 ). The current exercise intervention should not be recommended to patients recently treated with autologous stem cell transplantation.
Identifiants
pubmed: 31286387
doi: 10.1007/s11764-019-00775-9
pii: 10.1007/s11764-019-00775-9
pmc: PMC6677707
doi:
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
558-569Subventions
Organisme : KWF Kankerbestrijding
ID : ALPE 2009-4620
Références
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Health Econ. 2004 May;13(5):461-75
pubmed: 15127426
Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1574-8
pubmed: 16038162
Arch Phys Med Rehabil. 2007 May;88(5):610-6
pubmed: 17466730
Circulation. 2007 Aug 28;116(9):1081-93
pubmed: 17671237
J Sci Med Sport. 2009 Mar;12(2):310-6
pubmed: 18078784
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006145
pubmed: 18425939
Value Health. 2009 Jun;12(4):409-18
pubmed: 19900249
Bone Marrow Transplant. 2011 Sep;46(9):1245-55
pubmed: 21132025
BMC Cancer. 2010 Dec 06;10:671
pubmed: 21134270
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Oncologist. 2012;17(12):1581-93
pubmed: 22982580
Cancer Treat Rev. 2013 Oct;39(6):682-90
pubmed: 23485478
Cancer Treat Rev. 2014 Mar;40(2):327-40
pubmed: 23871124
J Cancer Surviv. 2015 Mar;9(1):126-35
pubmed: 25179578
Value Health. 2015 Mar;18(2):161-72
pubmed: 25773551
J Clin Oncol. 2015 Jun 10;33(17):1918-27
pubmed: 25918291
BMC Med. 2015 Jun 08;13:121
pubmed: 26050790
Acta Derm Venereol. 2016 May;96(4):499-504
pubmed: 26573488
J Sci Med Sport. 2017 Feb;20(2):116-122
pubmed: 26971299
Eur J Cancer Care (Engl). 2017 Nov;26(6):null
pubmed: 27726229
Cancer Treat Rev. 2017 Jan;52:91-104
pubmed: 28006694
BMC Health Serv Res. 2017 Jan 26;17(1):89
pubmed: 28126005
BMJ Open. 2017 Mar 6;7(3):e012187
pubmed: 28264824
Clin Transplant. 2017 Sep;31(9):null
pubmed: 28678411
PLoS One. 2017 Jul 20;12(7):e0181313
pubmed: 28727771
Curr Oncol. 2017 Aug;24(4):e290-e315
pubmed: 28874900
Br J Sports Med. 2018 Apr;52(8):505-513
pubmed: 28954800
Eur J Cancer Care (Engl). 2018 Jan;27(1):null
pubmed: 28960542
Eur J Health Econ. 2018 Jul;19(6):893-904
pubmed: 29086085
Crit Rev Oncol Hematol. 2018 Feb;122:52-59
pubmed: 29458789
J Cancer Surviv. 2018 Jun;12(3):417-429
pubmed: 29497963
Br J Sports Med. 2018 Oct;52(20):1311
pubmed: 29549149
Jpn J Clin Oncol. 2018 Dec 1;48(12):1046-1057
pubmed: 30277514
J Psychosom Res. 1995 Apr;39(3):315-25
pubmed: 7636775